Vericel Retained Earnings vs Current Deferred Revenue Analysis
VCEL Stock | USD 46.05 0.60 1.32% |
Vericel Corp financial indicator trend analysis is much more than just breaking down Vericel Corp Ord prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vericel Corp Ord is a good investment. Please check the relationship between Vericel Corp Retained Earnings and its Current Deferred Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Retained Earnings vs Current Deferred Revenue
Retained Earnings vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vericel Corp Ord Retained Earnings account and Current Deferred Revenue. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Vericel Corp's Retained Earnings and Current Deferred Revenue is -0.67. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Vericel Corp Ord, assuming nothing else is changed. The correlation between historical values of Vericel Corp's Retained Earnings and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Vericel Corp Ord are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Retained Earnings i.e., Vericel Corp's Retained Earnings and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | -0.67 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Vericel Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vericel Corp Ord current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. At this time, Vericel Corp's Selling General Administrative is quite stable compared to the past year. Enterprise Value is expected to rise to about 1.7 B this year, although the value of Tax Provision will most likely fall to about 331.1 K.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 113.9M | 126.8M | 142.0M | 149.1M | Cost Of Revenue | 50.2M | 54.6M | 61.9M | 65.0M |
Vericel Corp fundamental ratios Correlations
Click cells to compare fundamentals
Vericel Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vericel Corp fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 153.2M | 205.6M | 243.7M | 273.0M | 353.7M | 371.3M | |
Other Current Liab | 1.2M | 7.7M | 41K | 16.2M | 17.2M | 18.1M | |
Total Current Liabilities | 19.8M | 22.5M | 26.1M | 37.5M | 45.7M | 48.0M | |
Total Stockholder Equity | 111.1M | 134.3M | 170.5M | 192.3M | 226.0M | 237.2M | |
Property Plant And Equipment Net | 32.2M | 57.7M | 59.0M | 57.4M | 115.1M | 120.9M | |
Net Debt | 814K | 19.6M | (18.2M) | (3.5M) | 1.3M | 1.3M | |
Retained Earnings | (378.7M) | (375.8M) | (383.3M) | (400.0M) | (403.2M) | (383.0M) | |
Accounts Payable | 6.3M | 6.8M | 9.0M | 16.9M | 22.3M | 23.5M | |
Cash | 26.9M | 33.6M | 68.3M | 51.1M | 86.9M | 91.2M | |
Non Current Assets Total | 41.6M | 82.0M | 85.2M | 86.1M | 148.0M | 155.4M | |
Cash And Short Term Investments | 69.7M | 75.8M | 103.4M | 119.5M | 127.3M | 133.7M | |
Net Receivables | 32.2M | 34.5M | 37.4M | 46.5M | 58.4M | 61.3M | |
Common Stock Shares Outstanding | 44.2M | 47.3M | 46.5M | 47.1M | 47.6M | 50.0M | |
Liabilities And Stockholders Equity | 153.2M | 205.6M | 243.7M | 273.0M | 353.7M | 371.3M | |
Non Current Liabilities Total | 22.4M | 48.9M | 47.2M | 43.3M | 82.0M | 86.1M | |
Other Current Assets | 3.0M | 3.9M | 4.2M | 4.8M | 6.9M | 7.2M | |
Other Stockholder Equity | 21K | 127.6M | 177.9M | 592.3M | 681.1M | 715.2M | |
Total Liab | 42.1M | 71.3M | 73.2M | 80.7M | 127.7M | 134.1M | |
Property Plant And Equipment Gross | 32.2M | 30K | 59.0M | 57.4M | 137.3M | 144.2M | |
Total Current Assets | 111.7M | 123.6M | 158.5M | 186.9M | 205.6M | 215.9M | |
Accumulated Other Comprehensive Income | 21K | 14K | (154K) | (978K) | (100K) | (105K) | |
Common Stock Total Equity | 489.7M | 6.6M | 553.9M | 593.2M | 682.2M | 716.3M | |
Short Term Investments | 42.8M | 42.2M | 35.1M | 68.5M | 40.5M | 42.5M | |
Common Stock | 489.7M | 510.1M | 553.9M | 593.2M | 629.2M | 660.7M | |
Inventory | 6.8M | 9.4M | 13.4M | 16.0M | 13.1M | 13.7M | |
Property Plant Equipment | 32.2M | 57.7M | 59.0M | 57.4M | 66.0M | 69.3M | |
Net Tangible Assets | 111.1M | 134.3M | 170.5M | 184.8M | 212.5M | 223.1M | |
Retained Earnings Total Equity | (378.7M) | (375.8M) | (383.3M) | (400.0M) | (360.0M) | (378.0M) | |
Non Currrent Assets Other | 89K | 211K | 528K | 1.3M | 771K | 732.5K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Vericel Stock analysis
When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.045 | Earnings Share (0.07) | Revenue Per Share 4.15 | Quarterly Revenue Growth 0.233 | Return On Assets (0.01) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.